Dignify Therapeutics is developing novel bowel and bladder therapies to restore voluntary control of voiding function and eliminate or reduce episodes of fecal and urinary incontinence.


Industries
Health
Biotechnology
Pharmaceuticals

Contact Information
Ed Burgard, PhD
President and Co-Founder
Dignify Therapeutics, LLC
PO Box 13169
2 Davis Drive
Research Triangle Park, NC 27709

Latest

Oct 22, 2024, 06:00 ET Dignify Therapeutics Selected as a Praxis SCI Accelerate Company

Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating company in...

Oct 15, 2024, 06:00 ET Dignify to highlight recent accomplishments at the 2024 BIO Investor Forum

Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Tony DiTonno, CEO and Executive...

Oct 09, 2024, 06:00 ET Dignify Therapeutics welcomes leading healthcare entrepreneurs Howard Palefsky and Neil Kurtz, MD to its Board of Directors

Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Howard Palefsky and Dr. Neil Kurtz ...

Oct 01, 2024, 06:00 ET Dignify Therapeutics to Participate in the BIO Investor Forum, October 2024

Dignify Therapeutics (Dignify), a specialty pharma company focused on resorting bowel and bladder function in patients with neurological diseases...

Sep 19, 2024, 06:00 ET Dignify Therapeutics awarded two new research grants from the National Institutes of Health (NIH)

Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, recently received two significant research grants ...

Aug 05, 2024, 07:00 ET Dignify Therapeutics welcomes leading spinal injury expert Alexander "Sasha" Rabchevsky PhD, to its Scientific Advisory Board

Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Dr. Rabchevsky has joined...

Mar 18, 2024, 06:00 ET Dignify Therapeutics Announces Anthony DiTonno as Chief Executive Officer

Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and bladder control for elderly...

Sep 13, 2023, 06:05 ET Dignify Therapeutics and Aayam Therapeutics enter into licensing agreement for novel on-demand defecation drug

Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and bladder control for elderly...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE